Method of determining metastatic potential of bladder tumor cells
US5382521A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jul 14, 1992 |
| Grant date | Jan 17, 1995 |
| Priority date | — |
| Expiry date | Jul 14, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/828
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods and compositions useful in the screening of human bladder cancer cells and malignant tumors are provided. Certain human autocrine motility factor receptors or proteins (gp78-hAMFR) have been identified which are useful in the screening of human bladder cancer cells and malignant tumors. Methods and assay kits for the screening of human bladder cancer, human cancer cells, and tumors, are provided wherein antibodies or other probes are used which recognize gp78-hAMFR expression. These methods and assays readily distinguish between non-malignant and malignant cancer cells and tumors and can be used to gauge metastatic potential.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.